Schedule 13D ownership disclosure

OptimizeRx Corp

Common Stock, par value $0.001 · CUSIP: 68401U204

Event date: 2025-03-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Whetstone Capital Advisors, LLCReported CIK 0001607278

    Shares: 1,508,303 · Class: 8.2%

  • David Atterbury

    Shares: 1,508,303 · Class: 8.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-036537
Form type
SCHEDULE 13D/A
Filer
OptimizeRx Corp
CIK
CIK 1448431
Filed
Mar 10, 2025
Reporting period
Mar 06, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub